Filing Flows › Stemtech (STEK) › Q2 2026 › vs Q1 2026
Stemtech (STEK) Q2 2026 vs Q1 2026 (quarter over quarter)
Stemtech's revenue rose $166K (+36%) from $463K in Q1 2026 to $629K in Q2 2026.
Stemtech, Q2 2026: revenue $629K (-10% year over year), operating margin -20.0%, net loss $292K, operating cash flow −$55K. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $629K | $463K | $166K | +36% |
| Net loss | $292K | $1.3M | −$961K | -77% |
| Costs & expenses | $922K | $1.7M | −$794K | -46% |
| Operating costs | $755K | $1.6M | −$802K | -52% |
| Interest & other, net | $167K | $159K | $8K | +5% |
| Cost of revenue | $164K | $109K | $54K | +50% |
| General & admin | $540K | $1.4M | −$859K | -61% |
| Other operating costs | $52K | $49K | $3K | +5% |
| Operating cash sources | $292K | $1.3M | −$961K | -77% |
| Depreciation & amortization | $42K | $42K | $0 | 0% |
| Share-based compensation | $109K | $108K | $1K | +1% |
| Working capital & other | $86K | $677K | −$591K | -87% |
| Cash used in operations | $55K | $426K | −$371K | -87% |
| Net loss absorbed | $292K | $1.3M | −$961K | -77% |
Questions
How much did Stemtech's revenue grow quarter over quarter in Q2 2026?
Stemtech's revenue rose $166K (+36%) from $463K in Q1 2026 to $629K in Q2 2026.